Raleigh, NC (PressExposure) August 05, 2008 -- The Eastern North Carolina Chapter of the National Multiple Sclerosis Society announces that Christopher Viehbacher, president of North American Pharmaceuticals for GlaxoSmithKline (GSK), will chair its annual Dinner of Champions (www.MSDinnerofChampions.org). The event, taking place on September 4 at Prestonwood Country Club, celebrates the positive contributions made by health and life sciences organizations.
âWe are both excited and grateful to have Chris as part of this yearâs event,â says Bob Bryan, president of the Eastern North Carolina Chapter of the National Multiple Sclerosis Society. âHis extensive involvement and leadership in the pharmaceutical industry has played an intricate role in restoring its competitiveness and fueling the industryâs success.â
In addition to celebrating the positive contributions made by organizations in the health and life sciences, the Dinner of Champions will raise money to support the organizationâs Access to Health Care Fund that aims to improve the access to health care for people affected by multiple sclerosis in eastern North Carolina.
âMultiple Sclerosis is the number one disabling disease among young adults in the U.S., and even though weâve come a long way in managing the disease, we must press on,â says Viehbacher. âWhether we are offering patient services or working tirelessly in the lab, we owe it to the 4,300 people in eastern North Carolina living with MS and patients everywhere to find new treatments. Iâm pleased to chair this yearâs dinner and focus greater attention on the needs of MS patients.â
Visit [http://www.MSDinnerofChampions.org], or call 919-834-0678 for more details.
About Christopher A. Viehbacher: For more than 20 years, Chris Viehbacher has been a powerful leader in the pharmaceutical industry. He joined North American Pharmaceuticals, GlaxoSmithKline when it was WellCome GmbH, Germany. In 2002, he served as one of two industry representatives on the G10 High Level Working Group sponsored by the European Commission to restore the competitiveness of the EU Pharmaceutical Industry. In 2003, the French Republic recognized Chris with is prestigious LÃ©gion d'Honneur award for his contributions to business and healthcare. Viehbacher was named head of North American Pharmaceuticals in May 2008 and currently serves as president of North American Pharmaceuticals, GlaxoSmithKline.